HC Wainwright & Co. Reiterates Buy on Affimed, Maintains $10 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. has reiterated its Buy rating for Affimed (NASDAQ:AFMD) and maintained a price target of $10, indicating confidence in the company's future performance.
September 06, 2024 | 10:21 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
HC Wainwright & Co. has reiterated its Buy rating for Affimed, maintaining a $10 price target. This suggests confidence in Affimed's potential for growth and could positively influence investor sentiment.
The reiteration of a Buy rating and maintenance of a $10 price target by HC Wainwright & Co. indicates strong confidence in Affimed's future performance. Such analyst ratings can positively impact investor sentiment and potentially lead to a short-term increase in stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100